特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
761699

細胞治療の世界市場:市場規模・現状・将来予測 (2019~2025年)

Global Cell Therapy Market Size, Status and Forecast 2019-2025

出版日: | 発行: QYResearch | ページ情報: 英文 101 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.56円
細胞治療の世界市場:市場規模・現状・将来予測 (2019~2025年)
出版日: 2019年07月09日
発行: QYResearch
ページ情報: 英文 101 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の細胞治療の市場について分析し、業界の基本構造や背景事情・最新情勢、全体的な市場規模の動向見通し、種類別・用途別および地域別の詳細動向、企業別の市場シェア構造、主要企業のプロファイル、今後の市場成長の可能性・方向性などを調査しております。

第1章 分析概要

  • 分析範囲
  • 主な市場区分
  • 分析対象企業
  • 市場分析:種類別
    • 市場規模・成長率:種類別 (通算12年間分)
    • 自家細胞移植
    • 同種異系細胞移植
  • 市場分析:用途別
    • 市場規模・成長率:用途別 (通算12年間分)
    • 病院・診療所
    • 日帰り手術センター (ASC)
    • 再生医療センター
  • 分析目的
  • 分析対象期間

第2章 世界市場の成長動向

  • 細胞治療の市場規模
  • 細胞治療の市場成長率の動向:地域別
    • 地域別の市場規模 (通算12年間分)
    • 地域別の市場シェア (過去6年間分)
  • 産業動向
    • 市場の主な動向
    • 市場促進要因
    • 市場機会

第3章 主要企業の市場シェア

  • 細胞治療の市場規模:メーカー別
    • 市場規模:メーカー別
    • 市場シェア:メーカー別
    • 市場集中度 (上位5社分、HHI指数)
  • 主要企業の本社所在地・活動地域
  • 主要企業の製品/ソリューション/サービス
  • 細胞治療市場への参入時期
  • 企業合併・買収 (M&A)/事業拡張計画

第4章 市場データの内訳:種類別・用途別

  • 種類別の市場規模 (過去6年間分)
  • 用途別の市場規模 (過去6年間分)

第5章 米国市場

  • 細胞治療の市場規模 (過去6年間分)
  • 国内の主要企業
  • 市場規模:種類別
  • 市場規模:用途別

第6章 欧州市場

第7章 中国市場

第8章 日本市場

第9章 東南アジア市場

第10章 インド市場

第11章 中南米市場

第12章 主要企業のプロファイル

  • Dendreon
    • 企業基本データ
    • 事業概要
    • 細胞治療事業:概略
    • 細胞治療事業:市場収益額 (過去6年間分)
    • 近年の主な動向
  • Mesoblast
  • Vericel
  • Novartis AG
  • GlaxoSmithKline plc
  • MEDIPOST
  • Osiris
  • PHARMICELL
  • NuVasive, Inc.
  • JCR Pharmaceuticals Co., Ltd
  • ANTEROGEN.CO.,LTD.
  • Cynata
  • CELLECTIS
  • BioNTech IMFS
  • EUFETS GmbH
  • Cognate
  • Pluristem
  • Grupo Praxis
  • Genzyme Corporation
  • Advanced Tissue

第13章 市場予測

  • 市場規模の予測値:地域別 (今後7年間分)
  • 米国市場の予測
  • 欧州市場の予測
  • 中国市場の予測
  • 日本市場の予測
  • 東南アジア市場の予測
  • インド市場の予測
  • 中南米市場の予測
  • 市場規模の予測値:製品別 (今後7年間分)
  • 市場規模の予測値:用途別 (今後7年間分)

第14章 アナリストの見解/結論

第15章 付録

図表

List of Tables and Figures

  • Table Cell Therapy Key Market Segments
  • Table Key Players Cell Therapy Covered
  • Table Global Cell Therapy Market Size Growth Rate by Type 2014-2025 (Million US$)
  • Figure Global Cell Therapy Market Size Market Share by Type 2014-2025
  • Figure Autologous Figures
  • Table Key Players of Autologous
  • Figure Allogeneic Figures
  • Table Key Players of Allogeneic
  • Table Global Cell Therapy Market Size Growth by Application 2014-2025 (Million US$)
  • Figure Hospitals and clinics Case Studies
  • Figure ASCs Case Studies
  • Figure Regenerative medicine centers Case Studies
  • Figure Cell Therapy Report Years Considered
  • Table Global Cell Therapy Market Size 2014-2025 (Million US$)
  • Figure Global Cell Therapy Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Cell Therapy Market Size by Regions 2014-2025 (Million US$)
  • Table Global Cell Therapy Market Size by Regions 2014-2019 (Million US$)
  • Table Global Cell Therapy Market Share by Regions 2014-2019
  • Figure Global Cell Therapy Market Share by Regions 2014-2019
  • Figure Global Cell Therapy Market Share by Regions 2019
  • Table Market Top Trends
  • Table Global Cell Therapy Revenue by Manufacturers (2014-2019) (Million US$)
  • Table Global Cell Therapy Market Share by Manufacturers (2014-2019)
  • Figure Global Cell Therapy Market Share by Manufacturers in 2018
  • Table Global Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Cell Therapy Product/Solution/Service
  • Table Date of Enter into Cell Therapy Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Cell Therapy Market Size by Type (2014-2019) (Million US$)
  • Table Global Cell Therapy Market Size Share by Type (2014-2019)
  • Figure Global Cell Therapy Market Size Market Share by Type (2014-2019)
  • Table Global Cell Therapy Market Size by Application (2014-2019) (Million US$)
  • Table Global Cell Therapy Market Size Share by Application (2014-2019)
  • Figure Global Cell Therapy Market Size Market Share by Application (2014-2019)
  • Figure Global Cell Therapy Revenue Market Share by Application in 2018
  • Figure United States Cell Therapy Market Size 2014-2019 (Million US$)
  • Table United States Key Players Cell Therapy Revenue (2018-2019) (Million US$)
  • Table United States Key Players Cell Therapy Market Share (2018-2019)
  • Table United States Cell Therapy Market Size by Type (2014-2019) (Million US$)
  • Table United States Cell Therapy Market Share by Type (2014-2019)
  • Table United States Cell Therapy Market Size by Application (2014-2019) (Million US$)
  • Table United States Cell Therapy Market Share by Application (2014-2019)
  • Figure Europe Cell Therapy Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Cell Therapy Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Cell Therapy Market Share (2018-2019)
  • Table Europe Cell Therapy Market Size by Type (2014-2019) (Million US$)
  • Table Europe Cell Therapy Market Share by Type (2014-2019)
  • Table Europe Cell Therapy Market Size by Application (2014-2019) (Million US$)
  • Table Europe Cell Therapy Market Share by Application (2014-2019)
  • Figure China Cell Therapy Market Size 2014-2019 (Million US$)
  • Table China Key Players Cell Therapy Revenue (2018-2019) (Million US$)
  • Table China Key Players Cell Therapy Market Share (2018-2019)
  • Table China Cell Therapy Market Size by Type (2014-20189) (Million US$)
  • Table China Cell Therapy Market Share by Type (2014-2019)
  • Table China Cell Therapy Market Size by Application (2014-2019) (Million US$)
  • Table China Cell Therapy Market Share by Application (2014-2019)
  • Figure Japan Cell Therapy Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Cell Therapy Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Cell Therapy Market Share (2018-2019)
  • Table Japan Cell Therapy Market Size by Type (2014-2019) (Million US$)
  • Table Japan Cell Therapy Market Share by Type (2014-2019)
  • Table Japan Cell Therapy Market Size by Application (2014-2019) (Million US$)
  • Table Japan Cell Therapy Market Share by Application (2014-2019)
  • Figure Southeast Asia Cell Therapy Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Cell Therapy Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Cell Therapy Market Share (2018-2019)
  • Table Southeast Asia Cell Therapy Market Size by Type (2014-2019) (Million US$)
  • Table Southeast Asia Cell Therapy Market Share by Type (2014-2019)
  • Table Southeast Asia Cell Therapy Market Size by Application (2014-2019) (Million US$)
  • Table Southeast Asia Cell Therapy Market Share by Application (2014-2019)
  • Figure India Cell Therapy Market Size 2014-2019 (Million US$)
  • Table India Key Players Cell Therapy Revenue (2018-2019) (Million US$)
  • Table India Key Players Cell Therapy Market Share (2018-2019)
  • Table India Cell Therapy Market Size by Type (2014-2019) (Million US$)
  • Table India Cell Therapy Market Share by Type (2014-2019)
  • Table India Cell Therapy Market Size by Application (2014-2019) (Million US$)
  • Table India Cell Therapy Market Share by Application (2014-2019)
  • Figure Central & South America Cell Therapy Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Cell Therapy Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Cell Therapy Market Share (2018-2019)
  • Table Central & South America Cell Therapy Market Size by Type (2014-2019) (Million US$)
  • Table Central & South America Cell Therapy Market Share by Type (2014-2019)
  • Table Central & South America Cell Therapy Market Size by Application (2014-2019) (Million US$)
  • Table Central & South America Cell Therapy Market Share by Application (2014-2019)
  • Table Dendreon Company Details
  • Table Dendreon Revenue in Cell Therapy Business (2014-2019) (Million US$)
  • Figure Dendreon Revenue Growth Rate in Cell Therapy Business (2014-2019)
  • Table Dendreon Recent Development
  • Table Mesoblast Company Details
  • Table Mesoblast Revenue in Cell Therapy Business (2014-2019)(Million US$)
  • Figure Mesoblast Revenue Growth Rate in Cell Therapy Business (2014-2019)
  • Table Mesoblast Recent Development
  • Table Vericel Company Details
  • Table Vericel Revenue in Cell Therapy Business (2014-2019)(Million US$)
  • Figure Vericel Revenue Growth Rate in Cell Therapy Business (2014-2019)
  • Table Vericel Recent Development
  • Table Novartis AG Company Details
  • Table Novartis AG Revenue in Cell Therapy Business (2014-2019)(Million US$)
  • Figure Novartis AG Revenue Growth Rate in Cell Therapy Business (2014-2019)
  • Table Novartis AG Recent Development
  • Table GlaxoSmithKline plc Company Details
  • Table GlaxoSmithKline plc Revenue in Cell Therapy Business (2014-2019)(Million US$)
  • Figure GlaxoSmithKline plc Revenue Growth Rate in Cell Therapy Business (2014-2019)
  • Table GlaxoSmithKline plc Recent Development
  • Table MEDIPOST Company Details
  • Table MEDIPOST Revenue in Cell Therapy Business (2014-2019)(Million US$)
  • Figure MEDIPOST Revenue Growth Rate in Cell Therapy Business (2014-2019)
  • Table MEDIPOST Recent Development
  • Table Osiris Company Details
  • Table Osiris Revenue in Cell Therapy Business (2014-2019)(Million US$)
  • Figure Osiris Revenue Growth Rate in Cell Therapy Business (2014-2019)
  • Table Osiris Recent Development
  • Table PHARMICELL Company Details
  • Table PHARMICELL Revenue in Cell Therapy Business (2014-2019)(Million US$)
  • Figure PHARMICELL Revenue Growth Rate in Cell Therapy Business (2014-2019)
  • Table PHARMICELL Recent Development
  • Table NuVasive, Inc. Company Details
  • Table NuVasive, Inc. Revenue in Cell Therapy Business (2014-2019)(Million US$)
  • Figure NuVasive, Inc. Revenue Growth Rate in Cell Therapy Business (2014-2019)
  • Table NuVasive, Inc. Recent Development
  • Table JCR Pharmaceuticals Co., Ltd Company Details
  • Table JCR Pharmaceuticals Co., Ltd Revenue in Cell Therapy Business (2014-2019)(Million US$)
  • Figure JCR Pharmaceuticals Co., Ltd Revenue Growth Rate in Cell Therapy Business (2014-2019)
  • Table JCR Pharmaceuticals Co., Ltd Recent Development
  • Table ANTEROGEN.CO.,LTD. Company Details
  • Table Cynata Company Details
  • Table CELLECTIS Company Details
  • Table BioNTech IMFS Company Details
  • Table EUFETS GmbH Company Details
  • Table Cognate Company Details
  • Table Pluristem Company Details
  • Table Grupo Praxis Company Details
  • Table Genzyme Corporation Company Details
  • Table Advanced Tissue Company Details
  • Table Global Cell Therapy Market Size by Regions (Million US$) 2019-2025
  • Figure Global Cell Therapy Market Size Share by Regions (2019-2025)
  • Figure Global Cell Therapy Market Size Share by Regions in 2025
  • Figure United States Cell Therapy Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Cell Therapy Market Size Forecast (2019-2025)(Million USD)
  • Figure China Cell Therapy Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Cell Therapy Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Cell Therapy Market Size Forecast (2019-2025)(Million USD)
  • Figure India Cell Therapy Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Cell Therapy Market Size Forecast (2019-2025)(Million USD)
  • Table Global Cell Therapy Market Size by Product (2019-2025) (Million US$)
  • Figure Global Cell Therapy Market Size by Product (2019-2025)
  • Figure Global Cell Therapy Market Size by Product in 2025
  • Table Global Cell Therapy Market Size by Application (2019-2025) (Million US$)
  • Figure Global Cell Therapy Market Size by Application (2019-2025)
  • Figure Global Cell Therapy Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.

Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The growing number of clinical trials, government and private funding, and increasing number of partnerships between companies are driving the growth of the global cell therapy market. Cell therapy products that are available in the market are based on autologous and allogenic cells. The demand of cell therapy treatment is increasing. This is because cell therapy products can be used for personalized treatment.

In 2018, the global Cell Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Therapy development in United States, Europe and China.

The key players covered in this study

  • Dendreon
  • Mesoblast
  • Vericel
  • Novartis AG
  • GlaxoSmithKline plc
  • MEDIPOST
  • Osiris
  • PHARMICELL
  • NuVasive, Inc.
  • JCR Pharmaceuticals Co., Ltd
  • ANTEROGEN.CO.,LTD.
  • Cynata
  • CELLECTIS
  • BioNTech IMFS
  • EUFETS GmbH
  • Cognate
  • Pluristem
  • Grupo Praxis
  • Genzyme Corporation
  • Advanced Tissue

Market segment by Type, the product can be split into

  • Autologous
  • Allogeneic

Market segment by Application, split into

  • Hospitals and clinics
  • ASCs
  • Regenerative medicine centers

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Cell Therapy status, future forecast, growth opportunity, key market and key players.
  • To present the Cell Therapy development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cell Therapy are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Cell Therapy Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Autologous
    • 1.4.3 Allogeneic
  • 1.5 Market by Application
    • 1.5.1 Global Cell Therapy Market Share by Application (2014-2025)
    • 1.5.2 Hospitals and clinics
    • 1.5.3 ASCs
    • 1.5.4 Regenerative medicine centers
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Cell Therapy Market Size
  • 2.2 Cell Therapy Growth Trends by Regions
    • 2.2.1 Cell Therapy Market Size by Regions (2014-2025)
    • 2.2.2 Cell Therapy Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Opportunities

3 Market Share by Key Players

  • 3.1 Cell Therapy Market Size by Manufacturers
    • 3.1.1 Global Cell Therapy Revenue by Manufacturers (2014-2019)
    • 3.1.2 Global Cell Therapy Revenue Market Share by Manufacturers (2014-2019)
    • 3.1.3 Global Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.2 Cell Therapy Key Players Head office and Area Served
  • 3.3 Key Players Cell Therapy Product/Solution/Service
  • 3.4 Date of Enter into Cell Therapy Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Cell Therapy Market Size by Type (2014-2019)
  • 4.2 Global Cell Therapy Market Size by Application (2014-2019)

5 United States

  • 5.1 United States Cell Therapy Market Size (2014-2019)
  • 5.2 Cell Therapy Key Players in United States
  • 5.3 United States Cell Therapy Market Size by Type
  • 5.4 United States Cell Therapy Market Size by Application

6 Europe

  • 6.1 Europe Cell Therapy Market Size (2014-2019)
  • 6.2 Cell Therapy Key Players in Europe
  • 6.3 Europe Cell Therapy Market Size by Type
  • 6.4 Europe Cell Therapy Market Size by Application

7 China

  • 7.1 China Cell Therapy Market Size (2014-2019)
  • 7.2 Cell Therapy Key Players in China
  • 7.3 China Cell Therapy Market Size by Type
  • 7.4 China Cell Therapy Market Size by Application

8 Japan

  • 8.1 Japan Cell Therapy Market Size (2014-2019)
  • 8.2 Cell Therapy Key Players in Japan
  • 8.3 Japan Cell Therapy Market Size by Type
  • 8.4 Japan Cell Therapy Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Cell Therapy Market Size (2014-2019)
  • 9.2 Cell Therapy Key Players in Southeast Asia
  • 9.3 Southeast Asia Cell Therapy Market Size by Type
  • 9.4 Southeast Asia Cell Therapy Market Size by Application

10 India

  • 10.1 India Cell Therapy Market Size (2014-2019)
  • 10.2 Cell Therapy Key Players in India
  • 10.3 India Cell Therapy Market Size by Type
  • 10.4 India Cell Therapy Market Size by Application

11 Central & South America

  • 11.1 Central & South America Cell Therapy Market Size (2014-2019)
  • 11.2 Cell Therapy Key Players in Central & South America
  • 11.3 Central & South America Cell Therapy Market Size by Type
  • 11.4 Central & South America Cell Therapy Market Size by Application

12 International Players Profiles

  • 12.1 Dendreon
    • 12.1.1 Dendreon Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Cell Therapy Introduction
    • 12.1.4 Dendreon Revenue in Cell Therapy Business (2014-2019)
    • 12.1.5 Dendreon Recent Development
  • 12.2 Mesoblast
    • 12.2.1 Mesoblast Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Cell Therapy Introduction
    • 12.2.4 Mesoblast Revenue in Cell Therapy Business (2014-2019)
    • 12.2.5 Mesoblast Recent Development
  • 12.3 Vericel
    • 12.3.1 Vericel Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Cell Therapy Introduction
    • 12.3.4 Vericel Revenue in Cell Therapy Business (2014-2019)
    • 12.3.5 Vericel Recent Development
  • 12.4 Novartis AG
    • 12.4.1 Novartis AG Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Cell Therapy Introduction
    • 12.4.4 Novartis AG Revenue in Cell Therapy Business (2014-2019)
    • 12.4.5 Novartis AG Recent Development
  • 12.5 GlaxoSmithKline plc
    • 12.5.1 GlaxoSmithKline plc Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Cell Therapy Introduction
    • 12.5.4 GlaxoSmithKline plc Revenue in Cell Therapy Business (2014-2019)
    • 12.5.5 GlaxoSmithKline plc Recent Development
  • 12.6 MEDIPOST
    • 12.6.1 MEDIPOST Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Cell Therapy Introduction
    • 12.6.4 MEDIPOST Revenue in Cell Therapy Business (2014-2019)
    • 12.6.5 MEDIPOST Recent Development
  • 12.7 Osiris
    • 12.7.1 Osiris Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Cell Therapy Introduction
    • 12.7.4 Osiris Revenue in Cell Therapy Business (2014-2019)
    • 12.7.5 Osiris Recent Development
  • 12.8 PHARMICELL
    • 12.8.1 PHARMICELL Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Cell Therapy Introduction
    • 12.8.4 PHARMICELL Revenue in Cell Therapy Business (2014-2019)
    • 12.8.5 PHARMICELL Recent Development
  • 12.9 NuVasive, Inc.
    • 12.9.1 NuVasive, Inc. Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Cell Therapy Introduction
    • 12.9.4 NuVasive, Inc. Revenue in Cell Therapy Business (2014-2019)
    • 12.9.5 NuVasive, Inc. Recent Development
  • 12.10 JCR Pharmaceuticals Co., Ltd
    • 12.10.1 JCR Pharmaceuticals Co., Ltd Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Cell Therapy Introduction
    • 12.10.4 JCR Pharmaceuticals Co., Ltd Revenue in Cell Therapy Business (2014-2019)
    • 12.10.5 JCR Pharmaceuticals Co., Ltd Recent Development
  • 12.11 ANTEROGEN.CO.,LTD.
  • 12.12 Cynata
  • 12.13 CELLECTIS
  • 12.14 BioNTech IMFS
  • 12.15 EUFETS GmbH
  • 12.16 Cognate
  • 12.17 Pluristem
  • 12.18 Grupo Praxis
  • 12.19 Genzyme Corporation
  • 12.20 Advanced Tissue

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.